Salud

Pfizer anuncia exitoso resultado de su píldora anticovid: así funcionaría

Tratamiento llamado paxlovid redujo el riesgo de hospitalización y muerte en un 89% durante el ensayo clínico; farmacéutica pedirá autorización de uso de emergencia

(FILES) In this file photo taken on April 26, 2016, the Pfizer company logo  at Pfizer�s headquarters in New York. - People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published October 13, 2021 showed. (Photo by Don EMMERT / AFP)
(FILES) In this file photo taken on April 26, 2016, the Pfizer company logo at Pfizer�s headquarters in New York. - People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published October 13, 2021 showed. (Photo by Don EMMERT / AFP) DON EMMERT
‌
‌

‌

‌
‌

‌

‌